What makes physicians more likely to adopt new, cost-effective drugs? Male sex, comfort with risk, prescribing volume, seniority, spending less time in consultation, and practicing in affluent areas predicted early adoption of NOACs in Australia. https://t
1,116 followers
1,550 followers
@gratefull080504 @ChristosArgyrop @eric_weinhandl @GlassockJ @Nephro_Sparks @kidney_boy @ASN Therapeutic inertia’s not unique to SGLTis. Reasons include patient/provider concerns on cost/side effects, lack of knowledge. Also provider characteristics (e.g.
1,619 followers
New from #OfficialNIHR https://t.co/mcfGzrrT4c Factors affecting general practitioners’ decisions to adopt new prescription drugs – cohort analyses using Australian longitudinal physician survey data
2,627 followers
Factors affecting general practitioners’ decisions to adopt new prescription drugs – cohort analyses using Australian longitudinal physician survey data https://t.co/dBMINbtTJb #bmchealthservres